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Abstract
Study Design: Retrospective cohort study.
Objectives: To determine the effect of obesity (body mass index >30 kg/m2) on perioperative morbidity and mortality after
surgical decompression of spinal metastases.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database is a large multicenter
clinical registry that collects preoperative risk factors, intraoperative variables, and 30-day postoperative morbidity and mortality
outcomes from hospitals nationwide. Current Procedural Terminology codes were used to query the database for adults who
underwent decompression with laminectomy for treatment of metastatic spinal lesions between 2010 and 2014. Patients were
separated into 2 cohorts based on the presence of absence of obesity. Univariate analysis and multivariate logistic regression
analysis were used to analyze the effect of obesity on perioperative morbidity and mortality.
Results: There was a significantly higher rate of venous thromboembolism (VTE; obese 6.6% vs nonobese 4.2%; P ¼ .01) and
pulmonary complications (obese 2.6% vs nonobese 2.2%; P ¼ .046) in the obese group compared with the nonobese group. The
nonobese group had prolonged hospitalization (obese 62.0% vs nonobese 69.0%; P ¼ .001) and a higher incidence of blood
transfusions (obese 26.8% vs nonobese 34.2%; P < .001). On multivariate analysis, obesity was found to be an independent risk
factor for VTE (odds ratio ¼ 1.75, confidence interval ¼ 1.17-2.63, P ¼ .007).
Conclusions: Obese patients were predisposed to an elevated risk of VTE following laminectomy for spinal metastases. Early
postoperative mobilization and a low threshold to evaluate for perioperative VTE are important in these patients in order to
appropriately diagnose and treat these complications and minimize morbidity.
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Introduction
The spine is a common location for the development of primary
and metastatic tumors. Spinal metastases are the most common
tumor in the spine, accounting for more than 95% of spinal
tumors and more than 18 000 newly diagnosed cases in North
America each year.1 Surgical indications for spinal metastases
have expanded over the past few years to address symptoms of
neurological deficit and spinal instability.2
Currently, the effect of obesity on outcomes following sur-
gery for spinal metastases remains largely unknown. Obesity is
a national epidemic, and according to the Centers for Disease
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Control and Prevention, among 78 million American adults,
35.7% of the population is currently obese (ie, body mass index
[BMI] 30 kg/m2). Despite efforts geared toward optimizing
diets and losing weight preoperatively, a subgroup of patients
undergoing surgery for spinal metastases are inevitably obese.
Spine surgery in the setting of obesity is challenging due to
difficulties with anesthesia, intravenous access, positioning,
and physical access during the surgery itself.3 Furthermore,
obesity represents a systematic inflammatory state that can
affect postoperative recovery and fusion rates, which could
be particularly detrimental for patients with spinal metastases
who are frail and have poor physiological reserve.3 Although
several studies have demonstrated an increased risk of perio-
perative complications in patients with obesity, other studies
have shown contradicting findings.4
There are currently no studies in the literature analyzing the
relationship between obesity and perioperative outcomes fol-
lowing surgery for metastatic spinal tumors. In this study, we
used the American College of Surgeons National Surgical
Quality Improvement Program (ACS-NSQIP) database to
investigate the effect of obesity on 30-day perioperative com-
plications in patients undergoing decompressive laminectomy
for spinal metastases.
Methods
Patient Selection and Data Collection
We included data from the ACS-NSQIP database between
2010 and 2014. The ACS-NSQIP is a nationwide database that
collects data from over 600 hospitals. Based on medical chart
review, data on over 150 variables is collected by a trained and
certified Surgical Clinical Reviewer. The collected data
includes preoperative risk factors including patient demo-
graphics and comorbidities, surgical variables, and 30-day
postoperative outcomes and complications for patients under-
going surgical procedures.5 Adult patients aged 18 years or
older undergoing surgery for the treatment of metastatic spinal
lesions were included. We included only those patients under-
going laminectomy for decompression of extramedullary
spinal neoplasms in the cervical, thoracic, lumbar, and/or sacral
spine. Patients were separated into 2 cohorts: obese (World
Health Organization definition: BMI30 kg/m2) and nonobese
(BMI <30 kg/m2). Baseline patient characteristics and comor-
bidities, operative variables, and complications were identified.
Variable Definitions
Preoperative variables included obesity (30 kg/m2), diabetes
(non–insulin-dependent diabetes mellitus or insulin-dependent
diabetes mellitus), current smoking (within 1 year of surgery),
dyspnea (30 days prior to surgery), functional status prior to
surgery (independent or partially/totally dependent 30 days
prior to surgery), pulmonary comorbidity (ventilator dependent
48 hours prior to surgery or history of chronic obstructive
pulmonary disease 30 days prior to surgery), cardiac
comorbidity (use of hypertensive medication or history of
chronic heart failure 30 days prior to surgery), renal comor-
bidity (acute renal failure24 hours prior to surgery or dialysis
treatment 2 weeks prior to surgery), steroid use for chronic
condition (30 days prior to surgery), 10% loss of body
weight (in the past 6 months), bleeding disorder (chronic,
active condition), preoperative transfusion of 1 unit of
whole/packed red blood cells (72 hours prior to surgery),
concurrent fusion surgery (any approach), low platelet count
(<150 000), American Society of Anesthesiologists classifica-
tion3, nonelective surgery (includes patients who were trans-
ferred for operative treatment from another acute care hospital,
emergency department or clinic, undergoing emergent/urgent
surgery, or admitted to the hospital on the day(s) prior to a
scheduled procedure for any reason), thrombocytopenia (plate-
let count <150 000), preoperative anemia (male with hemato-
crit <40% or female with <36%), and prolonged operative time
(operative time 95th percentile of operative times in the
included cohort).
Thirty-day perioperative outcome variables included mor-
tality, wound complication (deep surgical site infection, organ
space infection, or wound dehiscence), pulmonary complica-
tion (pneumonia, unplanned reintubation, or ventilator-assisted
respiration 48 hours), venous thromboembolism (VTE; pul-
monary embolism or deep vein thrombosis), renal complication
(progressive renal insufficiency or acute renal failure), urinary
tract infection, cardiac complication (cardiac arrest requiring
cardiopulmonary resuscitation or myocardial infarction),
intraoperative or postoperative red blood cell transfusion, reo-
peration (related to initial procedure), prolonged length of stay
(LOS; 10 days), non–home discharge (discharge to another
acute care hospital, skilled care facility, non–skilled care facil-
ity, or rehabilitation), and unplanned readmission (related to
initial procedure). Further details about each of these variables
are described in the ACS-NSQIP guide.
Statistical Analysis
Baseline patient demographics, comorbidities, operative vari-
ables, and perioperative complications were analyzed. Baseline
patient and operative variables were compared between the
obese and nonobese groups. Categorical variables were
assessed using Pearson’s w2 test (or Fisher’s exact test where
appropriate). The incidence of perioperative complications was
then compared between the obese and nonobese groups.
Finally, multivariate logistic regression analysis was used to
determine 30-day perioperative complications that were inde-
pendently associated with obesity. Baseline patient and opera-
tive variables with P < .2 were then carried forward and
controlled for in this multivariate analysis. This specific meth-
odology was used in order to consider as many potential risk
factors as possible without including confounding variables.
This was important in order to avoid compromising the validity
of our regression models. Statistical significance was set at
the level of .05. The overall model was assessed using the
C-statistic, which is the area under the receiver operating
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characteristic curve. SAS software (Version 9.3, SAS Institute
Inc, Cary, NC) was used for all statistical analyses.
Results
Study Population
A total of 2202 adult patients with metastatic spinal tumors
undergoing laminectomy were identified. Within this cohort,
695 (31.6%) patients were obese. There were significant dif-
ferences between the obese and nonobese groups in terms of
sex, race, concurrent fusion, age, diabetes, cardiac comorbid-
ities, recent weight loss, preoperative transfusion, nonelective
surgery, and preoperative anemia (Table 1).
Univariate Analysis of the Incidence of
Perioperative Outcomes
A univariate analysis was performed to compare the incidence
of perioperative morbidity and mortality between the obese
and nonobese groups. Results of this univariate analysis are
outlined in Table 2. Obese patients had a higher incidence of
pulmonary complications (obese 2.6% vs nonobese 2.2%; P ¼
.050) and VTE (obese 6.6% vs nonobese 4.2%; P ¼ .010), and
a lower incidence of prolonged hospitalization (obese 62.0% vs
nonobese 69.0%; P ¼ .001) and blood transfusions (obese
26.8% vs nonobese 34.2%; P < .001).
Multivariate Analysis of Obesity as an Independent
Risk Factor for Perioperative Complications
We performed a multivariate analysis to examine the role of
obesity as an independent risk factor for 30-day perioperative
morbidity and mortality. Results of the multivariate logistic
regression analysis are outlined in Table 3. In order to avoid
potential confounding factors that were different between the 2
groups at baseline, we included patient and operative variables
that were significantly different or had P < .2 when compared
between the obese and nonobese groups (Table 1). These base-
line patient and operative variables were sex, race, age, dia-
betes, pulmonary comorbidity, cardiac comorbidity, recent
weight loss, preoperative anemia, preoperative blood transfu-
sion, hypoalbuminemia, nonelective surgery, and concurrent
fusion. After controlling for these baseline factors, we found
that obesity was an independent risk factor for VTE (odds ratio
¼ 1.75, 95% confidence interval ¼ 1.17-2.63, P ¼ .007) and a
protective factor against urinary tract infection (odds ratio ¼
0.38, 95% confidence interval ¼ 0.15-0.95, P ¼ .038). There
was no association between obesity and the other perioperative
complications included in this study.
Discussion
Despite the worsening epidemic of obesity in the United States,
there remains a paucity of data about its effect on clinical out-
comes following surgery for spinal metastases. Given the rel-
atively high prevalence of both obesity and spinal metastases,
careful analysis of patients who harbor both comorbidities has
important clinical merit. In this study, we investigated the
effect of obesity on 30-day perioperative complications follow-
ing laminectomy in patients with spinal metastases.
Perioperative complication rates following surgery for
spinal metastases are high.6 Previous studies have reported an
average perioperative complication rate of 26.9%, with rates
ranging from 5.3% to 76.2%.6,7 Studies have also reported on
multiple risk factors for increased morbidity following surgery
for metastatic spinal lesions, which include age, multilevel
disease, preoperative radiation, surgeon experience, myelopa-
thy, and preoperative Karnofsky Performance Score.8-13 How-
ever, obesity has not yet been studied as a potential risk factor
for surgical complications following operative decompression
of metastatic spinal tumors.
In this ACS-NSQIP study of 2202 patients, we found obesity
to be an independent predictor of VTE in patients undergoing
surgery for metastatic spinal tumors, with a 1.75 times
increased odds of VTE compared with nonobese patients. The
magnitude of this association is consistent with results from
smaller single-institution retrospective studies, which have
demonstrated a 2-fold increased risk of thromboembolic events
in obese patients.14,15 Potential mechanisms underlying this
Table 1. Baseline Patient and Operative Variables.
Category
Obese
(N ¼ 695), n (%)
Nonobese
(N ¼ 1507), n (%) P
Sex
Male 394 (56.77) 1004 (65.03) .0001
Female 298 (42.94) 540 (34.97)
Race
White 538 (78.65) 1132 (74.57) <.0001
Other 6 (0.88) 76 (5.01)
Black 76 (11.11) 150 (9.88)
Unknown 64 (9.36) 160 (10.54)
Concurrent fusion 298 (42.94) 788 (51.04) .0004
Age 65 228 (32.85) 616 (39.90) .0014
Diabetes 114 (16.43) 172 (11.14) .0007
Dyspnea 62 (8.93) 116 (7.51) .2551
Smoker 126 (18.16) 308 (19.95) .3189
Functional status
Independent 616 (88.76) 1372 (88.86) .9450
Partial or total
dependence
78 (11.24) 172 (11.14)
Pulmonary
comorbidity
44 (6.34) 70 (4.53) .0776
Cardiac comorbidity 400 (57.64) 628 (40.67) <.0001
Renal comorbidity 2 (0.29) 10 (0.65) .2542
Steroid use 78 (11.24) 152 (9.84) .3184
Recent weight loss 26 (3.75) 126 (8.16) <.0001
Bleeding disorder 40 (5.76) 72 (4.66) .2752
Preoperative RBC
transfusion
16 (2.31) 64 (4.15) .0241
Thrombocytopenia 86 (12.39) 204 (13.21) .5916
Nonelective surgery 288 (44.86) 702 (49.65) .0440
Preoperative anemia 296 (42.65) 850 (55.05) <.0001
Abbreviation: RBC, red blood cell.
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relationship include obstruction of venous return by abdominal
fat, chronically raised intra-abdominal pressure in obese
patients, and decreased blood velocity in the lower extremity
venous system.16,17 Furthermore, obesity has been associated
with endothelial dysfunction, oxidative stress, and increased
inflammation secondary to the release of nonesterified fatty
acids by excess visceral fat.17,18
Cancer patients are also at an increased risk of venous and
arterial thrombosis. Mortality rates of cancer patients with a
VTE are higher than in those patients without a VTE.19 The
increased thrombotic risk associated with cancer has long been
established. Malignant disease is found in 15% to 25% of all
patients with VTE.20-22 The prevalence of cancer is higher in
patients with an unprovoked thrombosis than in patients with
thrombosis secondary to a transient risk factor.23 The risk of
VTE is increased by 4- to 7-fold in patients with cancer.20,24
Our findings highlight the importance of encouraging early
postoperative mobilization as well as a low threshold for eva-
luation of VTE in the perioperative period in obese patients
with spinal metastases.
The obese group had a significantly higher incidence of
pulmonary complications than the nonobese group. This is
consistent with several studies that have found an association
between obesity and pulmonary complications.25-27 Obesity
has multiple effects on the respiratory system, including
increased work of breathing, reduced pulmonary compliance,
increased airway resistance, and reduced lung volume. Studies
have shown an increase in respiratory resistance related to a
decrease in functional residual capacity.28-30 Vaughan and
coworkers noted that obese patients have a significant preo-
perative reduction in arterial partial pressure of oxygen that
tends to worsen during the postoperative phase.31 Therefore,
these patients are more susceptible to respiratory complications
during the perioperative period, especially with regard to
respiratory weaning, prolonged mechanical ventilation, and
risk of pneumonia.32,33 Weaning mechanical ventilation is
often delayed in morbidly obese patients due to increased work
of breathing resulting from increased airway resistance, abnor-
mal chest elasticity, and inefficiency of the respiratory mus-
cles.34 Sharp et al have shown that the mechanical work needed
to passively ventilate subjects weighing 114 kg is 2 to 4 times
higher than that required for lighter individuals.28 The risk of
ventilator-associated pneumonia is also increased in obese
patients, likely because of higher gastric volume, lower normal
pH of gastric fluids, increased intra-abdominal pressure, and a
higher incidence of gastric reflux.35-37
Obese patients had a lower incidence of prolonged hospita-
lization compared with nonobese patients. This is an unex-
pected finding that is difficult to explain, as previous studies
examining outcomes after spinal surgery have found an asso-
ciation between obesity and prolonged LOS.38 Hauck and
Hollingsworth examined the impact of obesity on hospital LOS
across multiple medical and surgical subspecialties and found
that overall, medically managed obese patients tended to have a
longer LOS, while surgically treated patients had a shorter
LOS.39 One explanation they proposed to explain this trend
is that a smaller proportion of obese patients are indicated for
surgery in the first place, and this subgroup may represent those
patients at lowest risk for complications at baseline.39 Alterna-
tively, they suggested that perhaps obese patients are more
likely to die of complications.39 However, their results did not
provide any evidence to support either explanation for shorter
LOS in obese patients. As such, we do not have a good
Table 3. Multivariate Logistic Regression Analysis of Obesity as an









Venous thromboembolism 1.75 1.17-2.63 .007 .729
Urinary tract infection 0.38 0.15-0.95 .038 .778
aVariables that were controlled for include the following: sex, race, age, dia-
betes, pulmonary comorbidity, cardiac comorbidity, recent weight loss, pre-
operative anemia, preoperative blood transfusion, hypoalbuminemia,
nonelective surgery, and concurrent fusion.
Table 2. Univariate Analysis of 30-Day Perioperative Outcomes in the Obese and Nonobese Groups.
Category Obese (N ¼ 695), n (%) Nonobese (N ¼ 1507), n (%) P Total (N ¼ 2202), n (%)
Prolonged hospitalization (>75th%) 172 (24.7) 456 (30.3) .021 628 (28.5)
Wound complications 18 (2.6) 34 (2.3) .573 52 (2.5)
Pulmonary complications 18 (2.6) 33 (2.2) .046 51 (2.3)
Venous thromboembolism 46 (6.6) 64 (4.2) .014 110 (5.0)
Renal complications 6 (0.9) 6 (0.4) .170 12 (0.5)
Urinary tract infection 14 (2.0) 50 (3.3) .098 64 (2.9)
Cardiac complication 2 (0.3) 12 (0.8) .145 14 (0.6)
Intraoperative/postoperative transfusion 186 (26.8) 528 (35.0) <.001 714 (32.4)
Sepsis 28 (4.0) 60 (3.9) .868 88 (4.0)
Mortality 42 (6.0) 94 (6.2) .974 136 (6.2)
Discharge to non–home facility 264 (38.0) 548 (36.4) .366 812 (36.9)
Unplanned readmission 10 (1.4) 38 (2.5) .217 48 (2.2)
Reoperation related to initial procedure 34 (4.9) 70 (4.6) .747 104 (4.7)
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explanation for the observed association between obesity and a
decreased incidence of prolonged LOS in our study. This
should be examined further in future studies to better delineate
the underlying etiology of this association.
In our multivariate analysis, we did not find an association
between obesity and perioperative blood transfusions. How-
ever, in the univariate analysis, obese patients had a signifi-
cantly lower rate of blood transfusions compared with their
nonobese counterparts. Obese patients had a transfusion rate
of 26.8%, which is consistent with previous studies that have
found transfusion rates of 8% to 36% in patients undergoing
spinal surgery, with a tendency toward higher transfusion rates
in oncologic spinal surgery.40-42 Obese patients have a higher
estimated blood volume, and therefore, the amount of blood
lost as a proportion of estimated blood volume is lower for
obese patients compared with that of nonobese patients. Sim-
ilar to our findings, Frisch et al found that there was a signif-
icant decrease in the rate of perioperative blood transfusions
following total hip and knee arthroplasty in patients with
increased BMI.43 These findings suggest that the percentage
of estimated blood loss may be more predictive of blood trans-
fusion requirements, which may offer a plausible explanation
for the lower rate of perioperative transfusions observed in our
cohort of obese patients.
There are several limitations to the present study. First, the
ACS-NSQIP database is subject to various biases—including
selection bias and sampling bias—that are inherent in all stud-
ies that are based on data from registries. The ACS-NSQIP
database classifies cases based on Current Procedural Termi-
nology codes. However, Current Procedural Terminology
codes do not provide information about primary tumor
location or histology, which are both significant prognostic
predictors.44-46 The overall burden of disease and number of
vertebral and visceral metastases have also been associated
with poor prognosis but could not be analyzed with our data
set.47,48 Additionally, prognostic variables such as Karnofsky
Performance Score or postoperative functional status (eg,
paraparesis, paraplegia, etc) were not available in the ACS-
NSQIP database. Chemotherapy and radiation therapy were also
not accounted for in this database. Another limitation is that
outcomes were limited to 30 days after surgery with no long-
term follow-up. In this study, obesity was defined as a dichot-
omous variable only, and we did not subcategorize patients
further according to the degree of obesity due to the small num-
ber of patients that would have been in each subgroup. Future
studies should examine long-term outcomes of laminectomy in
obese patients with spinal metastases, as well as assess the
effect of increasing severity of obesity on surgical outcomes.
With these limitations in mind, the ACS-NSQIP database
provides a large sample size from multiple institutions nation-
wide to investigate the impact of obesity on 30-day periopera-
tive complications following laminectomy for spinal
metastases. Our findings demonstrate that obesity is an inde-
pendent predictive risk factor for VTE but was not a risk factor
for any other major perioperative complications. Given the
predisposition for VTE associated with malignancy itself,
obese patients with spinal metastases are at particularly high
risk for perioperative VTE following laminectomy. Surgeons
should be vigilant about promoting early mobilization post-
operatively as prophylaxis against VTE, as well as recognizing
early signs and symptoms of VTE in the perioperative period in
order to appropriately evaluate and treat these complications in
a timely fashion.
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